Literature DB >> 12644459

Type XXIII collagen, a new transmembrane collagen identified in metastatic tumor cells.

Jacqueline Banyard1, Lere Bao, Bruce R Zetter.   

Abstract

We have identified a transmembrane collagen, collagen XXIII, in rat prostate carcinoma cells. Differential display of mRNA expression in prostate carcinoma sublines with varying metastatic potential revealed overexpression of this transcript in the metastatic AT6.1 subline. cDNA cloning identified a 2733-bp transcript from AT6.1 RNA, encoding a protein of 532 amino acids, together with a 3067-bp human homologue, resulting in a 540-amino acid protein. Collagen XXIII is predicted to be a type II membrane protein consisting of an amino-terminal cytoplasmic domain, a transmembrane region, and three collagenous domains flanked by short noncollagenous domains. Collagen XXIII is a new member of the transmembrane collagen family, showing structural homology with the transmembrane collagens XIII and XXV. We present evidence that collagen XXIII is expressed as a approximately 75-kDa protein at the cell surface and that it can be cleaved by furin protease activity. Cleavage results in a approximately 60-kDa soluble protein that forms a multimeric complex and exhibits a low affinity interaction with heparin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644459     DOI: 10.1074/jbc.M210616200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  The shed ectodomain of type XIII collagen affects cell behaviour in a matrix-dependent manner.

Authors:  Marja-Riitta Väisänen; Timo Väisänen; Taina Pihlajaniemi
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

2.  A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis.

Authors:  K A Spivey; I Chung; J Banyard; I Adini; H A Feldman; B R Zetter
Journal:  Oncogene       Date:  2011-10-03       Impact factor: 9.867

3.  Collagen XXIII: a potential biomarker for the detection of primary and recurrent non-small cell lung cancer.

Authors:  Kristin A Spivey; Jacqueline Banyard; Luisa M Solis; Ignacio I Wistuba; Justine A Barletta; Leena Gandhi; Henry A Feldman; Scott J Rodig; Lucian R Chirieac; Bruce R Zetter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05       Impact factor: 4.254

4.  Collagen XXIII, novel ligand for integrin alpha2beta1 in the epidermis.

Authors:  Guido Veit; Daniela Zwolanek; Beate Eckes; Stephan Niland; Jarmo Käpylä; Manon C Zweers; Akemi Ishada-Yamamoto; Thomas Krieg; Jyrki Heino; Johannes A Eble; Manuel Koch
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

5.  Distinct microenvironmental cues stimulate divergent TLR4-mediated signaling pathways in macrophages.

Authors:  Anna M Piccinini; Lorena Zuliani-Alvarez; Jenny M P Lim; Kim S Midwood
Journal:  Sci Signal       Date:  2016-08-30       Impact factor: 8.192

Review 6.  Collagens.

Authors:  Marion K Gordon; Rita A Hahn
Journal:  Cell Tissue Res       Date:  2009-08-20       Impact factor: 5.249

7.  Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients.

Authors:  Kiyoshi Misawa; Takeharu Kanazawa; Atsushi Imai; Shiori Endo; Daiki Mochizuki; Hirofumi Fukushima; Yuki Misawa; Hiroyuki Mineta
Journal:  Mol Clin Oncol       Date:  2013-12-24

Review 8.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

9.  Postmortem detection of COL gene family variants in two aortic dissection cases.

Authors:  Meichen Pan; Yuning Wang; Lianjie Li; Zehao Li; Shifan Wu; Qian Liu
Journal:  Int J Legal Med       Date:  2021-06-14       Impact factor: 2.686

10.  Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.

Authors:  T Manon-Jensen; S Sun; M Lindholm; V Domislović; P Giuffrida; M Brinar; G Mazza; M Pinzani; Z Krznarić; A Di Sabatino; M A Karsdal; J H Mortensen
Journal:  United European Gastroenterol J       Date:  2021-03-29       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.